跳至主要内容
临床试验/ACTRN12618002054291
ACTRN12618002054291已完成不适用

Prophylactic tramadol versus nefopam for post-operative catheter-related bladder discomfort in patients undergoing elective per-cutaneous nephrolithotomy.A randomized controlled trial

South valley university0 个研究点目标入组 150 人开始时间: 2018年12月21日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • adult patients of either sex, ASA I or II, undergoing per cutaneous nephrolithotomy(PCNL) for renal upper ureteric stone requiring catheterization of urinary bladder . This procedure usually requires postoperative bladder drainage for 12-24 hours in addition to nephrostomy .

排除标准

  • -Bladder outflow obstruction.
  • -Overactive bladder( frequency > 3 times per night or mor than 8 times per 24 hours.
  • -Epilepsy.
  • -Myocardial ischemia or infarction , arrhythmia so, heart failure.
  • -Renal and hepatic diseases .
  • -Current use of mono amine oxidase inhibitors.
  • -History of drug abuse.
  • -Angle- closure glaucoma.
  • -Morbid obesity( BMI> 30 kg/ m2).
  • - History of chronic pain.

研究者

相似试验